Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Champions Oncology (CSBR) Leases (2016 - 2026)

Champions Oncology has reported Leases over the past 15 years, most recently at $4.0 million for Q1 2026.

  • Quarterly results put Leases at $4.0 million for Q1 2026, down 25.03% from a year ago — trailing twelve months through Jan 2026 was $4.0 million (down 25.03% YoY), and the annual figure for FY2025 was $5.1 million, down 18.75%.
  • Leases for Q1 2026 was $4.0 million at Champions Oncology, down from $4.3 million in the prior quarter.
  • Over the last five years, Leases for CSBR hit a ceiling of $8.4 million in Q1 2022 and a floor of $4.0 million in Q1 2026.
  • Median Leases over the past 5 years was $6.5 million (2024), compared with a mean of $6.4 million.
  • Biggest five-year swings in Leases: soared 56.47% in 2022 and later fell 25.03% in 2026.
  • Champions Oncology's Leases stood at $7.7 million in 2022, then decreased by 11.46% to $6.8 million in 2023, then dropped by 16.83% to $5.7 million in 2024, then fell by 23.3% to $4.3 million in 2025, then dropped by 7.41% to $4.0 million in 2026.
  • The last three reported values for Leases were $4.0 million (Q1 2026), $4.3 million (Q4 2025), and $4.8 million (Q3 2025) per Business Quant data.